🕵️ Fulgent Genetics, Inc. ($FLGT)
SEC insider & ownership activity, last 12 months · CIK 1674930 · every row links its SEC filing
Over the last 12 months insiders sold $678K with no open-market buying against it. Xie Jian sold $505K through a program of 8 sale notices averaging $97K (Nov–Sep). Ming Hsieh added 30.7% → 32.3%; The MING Hsieh Trust added 27.4% → 28.7%. No red-flag 8-Ks in the window.
🚨 2 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $678K (15 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Xie Jian | 0 | – | 8 | $505K | Sep 2, 2026 |
| Gao Hanlin | 0 | – | 7 | $173K | Sep 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ming Hsieh | 32.3% | 13D | May 22, 2026 | filing ↗ | |
| The MING Hsieh Trust | 28.7% | 13D | May 22, 2026 | filing ↗ | |
| Barclays PLC | 7.6% | 13G | May 13, 2025 | filing ↗ | |
| BlackRock, Inc. | 5.9% | 13G | Apr 3, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Xie Jian | $42K | Sep 2, 2026 | filing ↗ |
| Gao Hanlin | $33K | Sep 2, 2026 | filing ↗ |
| Xie Jian | $24K | Aug 27, 2026 | filing ↗ |
| Gao Hanlin | $19K | Aug 27, 2026 | filing ↗ |
| Xie Jian | $38K | Jun 2, 2026 | filing ↗ |
| Gao Hanlin | $31K | Dec 2, 2025 | filing ↗ |
| Xie Jian | $32K | Dec 2, 2025 | filing ↗ |
| Xie Jian | $36K | Nov 28, 2025 | filing ↗ |
| Gao Hanlin | $28K | Nov 28, 2025 | filing ↗ |
| Xie Jian | $21K | Nov 24, 2025 | filing ↗ |
| Gao Hanlin | $16K | Nov 24, 2025 | filing ↗ |
| Xie Jian | $290K | Nov 20, 2025 | filing ↗ |
| Xie Jian | $291K | Nov 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Jul 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 14, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Mar 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Earnings (2.02) | Feb 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 20, 2025 | filing ↗ |
| Other events (8.01) | Dec 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 20, 2025 | filing ↗ |
| Earnings (2.02) | Nov 7, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 7, 2025 | filing ↗ |
| Other events (8.01) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 20, 2025 | filing ↗ |